Buenos Aires - Delayed Quote • ARS Continental Urbana Sociedad Anónima Inversora (COUR.BA) Follow Compare 2,926.50 0.00 (0.00%) At close: July 23 at 5:00:00 PM GMT-3 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for COUR.BA 1D 5D 0.00% 1M 0.00% 6M 5,753.00% YTD 5,753.00% 1Y 5,753.00% 5Y 5,753.00% All 22,411.54% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations The 5 best performing stocks on the Nasdaq 100 in 2024 'Pharma Bro' Martin Shkreli Predicts Liquidation Doom For MicroStrategy Amid Fall Below $300, Says Bitcoin Will Hit $250K Without Michael Saylor This Is How Much Bigger MicroStrategy's Bitcoin Stash Is Than the Next-Largest Corporate Holding Q3 Earnings Highs And Lows: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks Fannie Mae & Freddie Mac going private is 'playing with fire': Expert These Stocks Moved the Most Today: Super Micro, Moderna, Nvidia, MicroStrategy, Tesla, Palantir, Sangamo, and More Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway Mullen Delays Annual Report, Proposes Reverse Stock Split; Stock Surges by Double Digits Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Top Midday Decliners 5 Top-Performing Dividend ETFs of 2H Yielding At Least 20%